Jumio Corporation v. FaceTec, Inc.

Visa, Inc.vsCortex MCP, Inc.

Visa filed an authorized response opposing Cortex MCP’s Director Review request, asserting that the request raises a new, forfeited factual dispute about the Oborne prior art and that the Board’s obviousness finding is well‑supported.

Valve CorporationvsImmersion Corporation

The PTAB issued a Final Written Decision finding all 19 challenged claims unpatentable. The Board adopted the Petitioner's interpretation of 'virtual detent,' defining it as vibrotactile feedback that simulates mechanical resistance, and found anticipation in Rosenberg I for all claims.

Ovid Therapeutics Inc.vsMarinus Pharmaceuticals, Inc.

Ovid Therapeutics Inc.'s IPR challenge against Marinus Pharmaceuticals, Inc. was denied by the PTAB on grounds of obviousness (103). The Board found that Petitioner failed to demonstrate a reasonable likelihood of prevailing in its challenges regarding plasma concentration limitations and priority.

PacifiCorp et al.vsMES, Inc.

MidAmerican Energy Company and Birchtech Corp. have settled their dispute over U.S. Patent No. 10,589,225, filing a joint motion to terminate the inter partes review as to MidAmerican. The motion cites 35 U.S.C. §317 and argues no merits decision has been made.

Samsung Electronics Co., Ltd. et al.vsHeadwater Research LLC

Samsung and Google filed a second IPR petition challenging all claims of Headwater Research's patent, but the USPTO denied institution based on a post‑filing PO stipulation. The petitioners request Director review, arguing the denial misapplies § 314(a) and threatens broader litigation.